Skip to main content

User account menu

Home
Data Sources
Studies
Institutions
Networks
What's new
Support

Home
Antidepressants withdrawal syndrome: a pharmacovigilance study in VigiBase®

Antidepressants withdrawal syndrome: a pharmacovigilance study in VigiBase®

First published 25/06/2021

Last updated 25/06/2021

EU PAS number:

EUPAS41765

Study

Finalised

Download as PDF

Secondary tabs

Administrative details Methodological aspects Data management Resources

Page content

Documents
Publications
ENCePP Seal

Documents

Study protocol

Initial protocol

Study protocol_WD Sd Antidepressants

English (237.72 KB - PDF) View document

Study results

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Conflicts of interest of investigators

EUPAS41765-41762

English (165.01 KB - PDF) View document

Composition of steering group and observers

EUPAS41765_steering group

English (78.2 KB - PDF) View document

Signed checklist for study protocols

EUPAS41765-41764

English (446.49 KB - PDF) View document

Share this page

HMA-EMA Catalogues of real-world data sources and studies

Privacy

Contact